These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Epidemiological description of and response to a large yellow fever outbreak in Edo state Nigeria, September 2018 - January 2019. Nwachukwu William E; Oladejo J; Ofoegbunam CM; Anueyiagu C; Dogunro F; Etiki SO; Dachung BI; Obiekea C; Aderoju B; Akanbi K; Adeyemi IT; Famokun GA; Emelife O; Osamwonyi IW; Ochu CL; Abiode A; Ireye F; Chukwuji M; Ipadeola O; Saiki M; Okudo I; Nwodo D; Oteri JA; Ilori E; Mba N; Ihekweazu C BMC Public Health; 2022 Aug; 22(1):1644. PubMed ID: 36042438 [TBL] [Abstract][Full Text] [Related]
44. What's Old Is New Again: The Re-emergence of Yellow Fever in Brazil and Vaccine Shortages. Chen LH; Kozarsky PE; Visser LG Clin Infect Dis; 2019 May; 68(10):1761-1762. PubMed ID: 30204852 [TBL] [Abstract][Full Text] [Related]
46. A public health risk assessment for yellow fever vaccination: a model exemplified by an outbreak in the state of São Paulo, Brazil. Ribeiro AF; Tengan C; Sato HK; Spinola R; Mascheretti M; França AC; Port-Carvalho M; Pereira M; Souza RP; Amaku M; Burattini MN; Coutinho FA; Lopez LF; Massad E Mem Inst Oswaldo Cruz; 2015 Apr; 110(2):230-4. PubMed ID: 25946247 [TBL] [Abstract][Full Text] [Related]
47. International risk of yellow fever spread from the ongoing outbreak in Brazil, December 2016 to May 2017. Dorigatti I; Hamlet A; Aguas R; Cattarino L; Cori A; Donnelly CA; Garske T; Imai N; Ferguson NM Euro Surveill; 2017 Jul; 22(28):. PubMed ID: 28749337 [TBL] [Abstract][Full Text] [Related]
48. Vaccination and Therapeutics: Responding to the Changing Epidemiology of Yellow Fever. Bifani AM; Ong EZ; de Alwis R Curr Treat Options Infect Dis; 2020; 12(4):398-409. PubMed ID: 33173445 [TBL] [Abstract][Full Text] [Related]
49. The response to re-emergence of yellow fever in Nigeria, 2017. Nwachukwu WE; Yusuff H; Nwangwu U; Okon A; Ogunniyi A; Imuetinyan-Clement J; Besong M; Ayo-Ajayi P; Nikau J; Baba A; Dogunro F; Akintunde B; Oguntoye M; Kamaldeen K; Fakayode O; Oyebanji O; Emelife O; Oteri J; Aruna O; Ilori E; Ojo O; Mba N; Nguku P; Ihekweazu C Int J Infect Dis; 2020 Mar; 92():189-196. PubMed ID: 31935537 [TBL] [Abstract][Full Text] [Related]
50. Yellow fever control in Cameroon: where are we now and where are we going? Wiysonge CS; Nomo E; Mawo J; Ofal J; Mimbouga J; Ticha J; Ndumbe PM BMC Med; 2008 Feb; 6():3. PubMed ID: 18261201 [TBL] [Abstract][Full Text] [Related]
51. Vaccination and Therapeutics: Responding to the Changing Epidemiology of Yellow Fever. Bifani AM; Ong EZ; de Alwis R Curr Treat Options Infect Dis; 2020; 12(3):349-360. PubMed ID: 32837338 [TBL] [Abstract][Full Text] [Related]
52. [Modern features of epidemiology and prophylaxis of yellow fever]. Liashenko NI; Lukin EP Voen Med Zh; 2010 Jun; 331(6):32-6. PubMed ID: 20731094 [TBL] [Abstract][Full Text] [Related]
53. Unpredictable checks of yellow fever vaccination certificates upon arrival in Tanzania. Schönenberger S; Hatz C; Bühler S J Travel Med; 2016 May; 23(5):. PubMed ID: 27296582 [TBL] [Abstract][Full Text] [Related]
54. Assessing the impact of preventive mass vaccination campaigns on yellow fever outbreaks in Africa: A population-level self-controlled case series study. Jean K; Raad H; Gaythorpe KAM; Hamlet A; Mueller JE; Hogan D; Mengistu T; Whitaker HJ; Garske T; Hocine MN PLoS Med; 2021 Feb; 18(2):e1003523. PubMed ID: 33600451 [TBL] [Abstract][Full Text] [Related]
60. Yellow fever: a disease that has yet to be conquered. Barrett AD; Higgs S Annu Rev Entomol; 2007; 52():209-29. PubMed ID: 16913829 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]